A Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants

Conditions: Herpes Zoster Interventions: Biological: HZ Vaccine (IN001); Biological: Placebo; Biological: Shingrix Sponsors: Shenzhen Shenxin Biotechnology Co., Ltd Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials